Comparison of Regulatory T Cells in Hemodialysis Patients and Healthy Controls

Abstract

Rapamycin-based expansion protocols should enable clinical trials of cell-based immunotherapy for the induction of tolerance to renal allografts using hemodialysis regulatory T cells.